Screening and Secondary Prevention Rheumatic Heart Disease Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age10-30
SponsorNational Institute of Cardiovascular Diseases, Pakistan

About this trial

After basic clinical screening including history and physical, Point of care ultrasound will be performed to look at Mitral, Aortic and Tricuspid Valves for regurgitation or stenosis. For patients with confirmed Rheumatic heart disease (RHD), treatment and referral depending on stage of disease. Antibiotic prescription could be shifted to community health workers delivering preventive medications via practical clinical algorithms, diagnostic tools, availability of appropriate antibiotics, and supportive supervision. Patients will have repeat imaging at 2 years and 5 years to look at the outcome of delayed progression of valve disease.

Eligibility criteria

Qualifiers

Rural communities in Sindh

Disqualifiers

Refused to participate in the study

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed